PeterBlankestijn University Medical Center UtrechtNetherlands

PeterBlankestijn
Curriculum vitae of Prof Peter J. Blankestijn Peter J. Blankestijn did his medical school and training in internal medicine at the Erasmus University and Erasmus Medical Center in Rotterdam and worked as a nephrologist at the department of Nephrology and Hypertension of the University Medical Center Utrecht (UMCU), the Netherlands. Main research activities include studies in humans. Subjects are: 1] hypertension, with special interest for hypertension in chronic kidney disease patients, for the sympathetic nervous system and renal denervation. 2] treatment and prevention of complications of chronic kidney disease patients, 3] hemodialysis techniques, and 4] treatment and prevention of complications of hemodialysis treatment. He was and is principal investigator of several multicenter studies, including SMASH, MASTERPLAN, CONTRAST, SYMPATHY and CONVINCE. He received multiple grants from (inter)national organizations as well as of pharmaceutical, dialysis and medical devices industries. He acquired a large grant in the HORIZON 2020 program of the European Commission as chair of the CONVINCE consortium. He is (co)author of approximately 400 papers in peer reviewed scientific medical journals (Google Scholar H-index 81, > 22.000 citations).
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/87150a7c4e77aa9f9f13d04c982d7826.jpg
First Name
Peter
Last Name
Blankestijn
Institution
Country.
Netherlands

Sunday, February 9, 2025

Time Session
9 a.m.
10:30 a.m.
DavidWheeler Chair University College LondonUnited Kingdom
Winston Wing ShingFung Chair Prince of Wales Hospital, Hong KongHong Kong, China
  • What Have We Learned From CONVINCE?
    PeterBlankestijn Oral Abstract Presenter University Medical Center UtrechtNetherlands
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter University of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    KateBramham Oral Abstract Presenter King's College LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter Associate Professor in Nephrology, Christian Medical College, Vellore, IndiaIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Brahmkamal Hall - Plenary Hall